9^th World Pediatric Infectious Disease Congress

Welcome Message

About Conference

The 9th World Pediatric Infectious Disease Congress, scheduled to take place on April 20–21, 2027, in Paris, France, will serve as a premier international platform dedicated to advancing knowledge, innovation, and collaboration in the prevention, diagnosis, and treatment of infectious diseases affecting children worldwide.

Under the theme, “Global Innovations for Healthier Children: Advancing Prevention, Diagnosis and Treatment,” Pediatric Infectious 2027 will bring together leading pediatricians, pediatric infectious disease specialists, clinicians, researchers, microbiologists, virologists, immunologists, epidemiologists, public health professionals, academicians, young researchers, and industry experts from around the world. The congress aims to address the evolving challenges of pediatric infectious diseases, including emerging and re-emerging infections, antimicrobial resistance, vaccine-preventable diseases, respiratory infections, neonatal and congenital infections, pediatric sepsis, viral diseases, and infections in immunocompromised children. With rapid developments in molecular diagnostics, genomics, vaccines, novel therapeutics, artificial intelligence, and digital health, the conference will provide an important opportunity to explore innovative approaches that are shaping the future of pediatric infection care.

Pediatric Infectious 2027 will feature an extensive scientific program comprising keynote lectures, plenary sessions, expert panel discussions, oral presentations, poster sessions, workshops, and interactive networking opportunities. The program will encourage participants to exchange scientific knowledge, share innovative research findings, discuss clinical experiences, and explore practical solutions to current and future challenges in pediatric infectious diseases. The congress will also highlight the growing importance of global collaboration in addressing infectious disease threats. Special attention will be given to antimicrobial resistance, emerging pathogens, pandemic preparedness, global vaccination strategies, climate-related infectious diseases, infection prevention, health equity, and improved access to diagnostics and treatment for children in diverse healthcare settings.

The conference offers an excellent opportunity for participants to present their latest research to an international audience, receive valuable feedback from experts, build professional networks, establish meaningful collaborations, and contribute to the advancement of child health. Researchers, clinicians, academicians, healthcare professionals, students, and industry representatives will have the opportunity to connect with multidisciplinary experts working across the field of pediatric infectious diseases.

Pediatric Infectious 2027 is more than a scientific meeting; it is a global gathering focused on creating meaningful progress for the health and well-being of children. By bringing together scientific expertise, innovative technologies, clinical experience, and global perspectives, the congress aims to strengthen the collective effort toward safer, healthier, and more resilient futures for children around the world.

Join us in Paris for two inspiring days of scientific excellence, innovation, knowledge exchange, and international collaboration as we work together to advance prevention, improve diagnosis, enhance treatment, and shape the future of pediatric infectious disease care.

Session & Tracks

The 9th World Pediatric Infectious Disease Congress 2027 offers a comprehensive scientific program covering the latest advances, challenges, and innovations in the prevention, diagnosis, treatment, and management of infectious diseases affecting children. The sessions are designed to bring together clinicians, researchers, scientists, academicians, healthcare professionals, and industry experts to exchange knowledge and explore evidence-based solutions to current and emerging pediatric health challenges.

The scientific tracks cover a broad range of topics, including emerging infections, antimicrobial resistance, vaccines and immunization, respiratory and viral diseases, neonatal infections, sepsis, tuberculosis, HIV, molecular diagnostics, genomics, artificial intelligence, digital health, global health, and pandemic preparedness. Each session will provide opportunities for scientific discussion, research presentations, clinical case sharing, and international collaboration.

Pediatric Infectious Diseases and Child Health

This session explores the overall burden of infectious diseases affecting children and their impact on health, development, and quality of life. It will address common and complex pediatric infections across different healthcare settings. Discussions will highlight advances in prevention, diagnosis, treatment, and long-term management. The session will also emphasize integrated approaches to improving child health worldwide.

Emerging and Re-emerging Pediatric Infections

This track focuses on infectious diseases that are newly emerging or returning as significant threats to children. Discussions will address changing disease patterns, new pathogens, and factors influencing disease transmission. Participants will explore surveillance, prevention, outbreak preparedness, and innovative response strategies. The session will highlight the importance of early detection and global collaboration.

Antimicrobial Resistance in Pediatrics

Antimicrobial resistance is a major global challenge affecting the effective treatment of pediatric infections. This session will examine resistant pathogens, inappropriate antimicrobial use, and challenges in treating multidrug-resistant infections. It will also explore surveillance systems and emerging approaches to combat resistance. Innovative therapeutic strategies and responsible antimicrobial practices will be discussed.

Antimicrobial Stewardship in Children

This session focuses on promoting the appropriate and responsible use of antimicrobial agents in pediatric care. It will address evidence-based prescribing, appropriate antibiotic selection, dosing, and duration of treatment. Participants will explore the role of stewardship programs and rapid diagnostics in improving clinical decision-making. The session aims to reduce unnecessary antimicrobial use and slow the development of resistance.

Pediatric Vaccine Development and Immunization

This track explores recent advances in vaccine research, development, and delivery for children. Discussions will cover new-generation vaccines, immunization strategies, and the expansion of vaccine-preventable disease programs. Experts will examine challenges in achieving high vaccination coverage across different populations. The session will also highlight innovations that can improve global protection for children.

Vaccine Safety and Vaccine Hesitancy

This session addresses the importance of vaccine safety monitoring and public confidence in immunization programs. Discussions will focus on effective communication, evidence-based information, and strategies to address vaccine hesitancy. Participants will explore factors influencing parental decisions and public perceptions of vaccines. The session aims to strengthen trust and improve childhood immunization coverage.

Maternal and Neonatal Immunization

This track focuses on the role of immunization during pregnancy and early life in protecting mothers and newborns. Discussions will explore maternal vaccination strategies and passive immune protection for infants. The session will address vaccine safety, timing, effectiveness, and implementation challenges. Participants will also examine future opportunities for improving protection during the earliest stages of life.

Respiratory Viral Infections

This session will cover the epidemiology, diagnosis, treatment, and prevention of viral respiratory infections in children. Discussions will include common respiratory viruses as well as emerging pathogens. Participants will explore disease severity, transmission patterns, and effective prevention strategies. The session will highlight advances in diagnostics and therapies for improving pediatric respiratory care.

Respiratory Syncytial Virus Infections

This track focuses on the significant burden of respiratory syncytial virus, particularly among infants and vulnerable children. Discussions will address clinical diagnosis, disease management, and prevention strategies. The session will highlight recent developments in vaccines and preventive therapies. Participants will also explore approaches to reducing severe disease and hospitalization.

Influenza and Viral Pneumonia

This session will explore influenza and other viral causes of pneumonia in children. Topics will include disease surveillance, diagnosis, clinical management, vaccination, and prevention. Participants will discuss factors associated with severe disease and complications. The session will also highlight strategies for improving preparedness during seasonal and emerging outbreaks.

COVID-19 and Post-Infectious Complications

This track will examine the continuing impact of COVID-19 on children and pediatric healthcare. Discussions will address acute infection, post-infectious complications, and long-term health outcomes. The session will explore prevention, vaccination, clinical management, and ongoing research. Participants will also discuss lessons learned for future pandemic preparedness.

Pediatric Tuberculosis

This session focuses on the challenges of diagnosing, preventing, and treating tuberculosis in children. Discussions will address drug-resistant tuberculosis, screening methods, and new diagnostic approaches. Participants will explore advances in treatment and prevention strategies. The session will also emphasize the importance of strengthening pediatric TB programs globally.

Pediatric HIV and AIDS

This track will explore advances in the prevention, diagnosis, and treatment of HIV among children and adolescents. Discussions will include early diagnosis, antiretroviral therapy, prevention of transmission, and long-term care. The session will address challenges faced by vulnerable populations and resource-limited settings. Emerging therapeutic and preventive strategies will also be highlighted.

Hepatitis and Liver Infections in Children

This session will address viral hepatitis and other infectious conditions affecting the liver in children. Topics will include diagnosis, prevention, treatment, and long-term monitoring. Participants will discuss the burden of hepatitis and challenges in early detection. The session will also highlight advances in therapeutic approaches and vaccination.

Neonatal Sepsis and Infections

This track focuses on the prevention, diagnosis, and management of infections during the neonatal period. Discussions will cover early-onset and late-onset sepsis, antimicrobial management, and rapid diagnostic approaches. Participants will explore strategies to reduce infection-related mortality and complications. The session will highlight innovations that can improve newborn outcomes.

Congenital and Perinatal Infections

This session explores infections transmitted during pregnancy, childbirth, and the early neonatal period. Discussions will include maternal screening, prevention of transmission, early diagnosis, and clinical management. Participants will examine the impact of these infections on fetal and newborn health. The session will emphasize prevention and early intervention strategies.

Pediatric Sepsis and Septic Shock

This track will focus on the early recognition and effective management of sepsis and septic shock in children. Discussions will address diagnostic tools, treatment strategies, fluid management, and critical care. Participants will explore approaches to reducing mortality and long-term complications. Emerging biomarkers and precision approaches to sepsis care will also be highlighted.

Central Nervous System Infections

This session will explore infectious diseases affecting the brain, spinal cord, and nervous system in children. Discussions will focus on diagnostic challenges, clinical manifestations, and appropriate treatment. Participants will examine emerging pathogens and neurological complications. The session will highlight advances in diagnostics and multidisciplinary management.

Meningitis and Encephalitis

This track focuses on the causes, diagnosis, treatment, and prevention of meningitis and encephalitis in children. Discussions will include bacterial, viral, and other infectious causes. Participants will explore rapid diagnostic approaches and strategies for reducing neurological complications. The session will also address vaccination and public health prevention.

Gastrointestinal and Foodborne Infections

This session will address common and emerging gastrointestinal infections affecting children. Topics will include diarrheal diseases, foodborne pathogens, dehydration, diagnostics, and treatment. Participants will explore prevention strategies and the role of food and water safety. The session will also highlight the global burden of enteric infections in children.

Urinary Tract Infections in Children

This track focuses on the diagnosis, treatment, prevention, and recurrence of urinary tract infections in children. Discussions will address antimicrobial resistance and appropriate antibiotic use. Participants will explore diagnostic challenges and strategies for identifying children at risk of recurrent infections. The session will emphasize evidence-based management and long-term care.

Bone and Joint Infections

This track focuses on osteomyelitis, septic arthritis, and other musculoskeletal infections in children. Discussions will address early diagnosis, imaging, microbiological testing, and treatment. Participants will explore multidisciplinary approaches to preventing complications and improving recovery. Advances in antimicrobial therapy and surgical management will also be discussed.

Pediatric Fungal Infections

This session will cover superficial and invasive fungal infections affecting children. Particular attention will be given to vulnerable and immunocompromised patients. Discussions will address early diagnosis, antifungal resistance, and emerging treatment approaches. The session will highlight strategies for improving outcomes in severe fungal infections.

Pediatric Parasitic Diseases

This track explores parasitic infections affecting children across different geographical regions. Discussions will include diagnosis, prevention, treatment, and the global burden of parasitic diseases. Participants will examine the influence of environmental and socioeconomic factors on disease transmission. The session will also address emerging challenges in parasite control.

Dengue and Arboviral Infections

This session will focus on dengue and other viral infections transmitted by mosquitoes and other arthropod vectors. Discussions will address disease surveillance, prevention, diagnosis, and clinical management in children. Participants will explore emerging threats and changing transmission patterns. The session will also highlight advances in vaccines and vector-control strategies.

Vector-Borne and Zoonotic Diseases

This track addresses infections transmitted through vectors and animals and their increasing importance in child health. Discussions will examine surveillance, prevention, environmental changes, and the One Health approach. Participants will explore the impact of climate change on disease transmission. The session will emphasize collaboration between human, animal, and environmental health sectors.

Infections in Immunocompromised Children

This track focuses on the prevention, diagnosis, and management of infections in children with weakened immune systems. Discussions will include children with primary immune disorders and those receiving immunosuppressive therapies. Participants will explore opportunistic infections and advanced prevention strategies. The session will emphasize individualized and multidisciplinary care.

Pediatric Oncology and Infectious Diseases

This session will address infectious complications in children undergoing cancer treatment. Topics will include neutropenia-related infections, fungal diseases, antimicrobial therapy, and infection prevention. Participants will explore strategies to improve early diagnosis and patient outcomes. The session will also highlight advances in supportive care.

Infection Prevention and Control

This track explores effective approaches to preventing the transmission of infectious diseases. Discussions will address infection control practices in hospitals, communities, schools, and pediatric settings. Participants will examine hygiene, vaccination, isolation, and surveillance strategies. The session will focus on strengthening systems that protect children and healthcare workers.

Healthcare-Associated Infections

This session focuses on infections acquired in hospitals and other healthcare settings. Discussions will address surveillance, prevention, antimicrobial resistance, and patient safety. Participants will explore strategies to reduce device-associated and procedure-related infections. The session will highlight the importance of effective infection-control programs.

Rapid Diagnostic Technologies

This session will highlight innovative point-of-care and rapid diagnostic tools for pediatric infections. Discussions will focus on reducing the time required to identify pathogens and guide treatment. Participants will explore the role of these technologies in hospitals and resource-limited settings. The session will emphasize their contribution to improved antimicrobial stewardship.

Genomics and Precision Medicine

This track examines the role of genomic technologies and precision medicine in pediatric infectious diseases. Discussions will address pathogen sequencing, host genetics, and personalized treatment approaches. Participants will explore how genomic information can improve diagnosis and disease management. The session will also highlight future opportunities for precision infection care.

Artificial Intelligence in Pediatric Infectious Diseases

This session explores the use of artificial intelligence and machine learning in pediatric infection care. Topics will include disease prediction, diagnosis, surveillance, clinical decision support, and data analysis. Participants will discuss the potential benefits and limitations of AI-based technologies. The session will highlight responsible and effective implementation in healthcare.

Digital Health and Telemedicine

This track focuses on digital technologies that can improve access to pediatric infectious disease care. Discussions will include telemedicine, remote monitoring, mobile health tools, and digital clinical platforms. Participants will explore how these technologies can support patients in underserved areas. The session will highlight opportunities and challenges in digital healthcare.

Pediatric Microbiome and Immune Health

This session will explore the relationship between the microbiome, immune development, and infectious diseases in children. Discussions will address the role of the gut microbiome in health and disease. Participants will examine probiotics, microbiome-based interventions, and the impact of antimicrobial use. The session will highlight emerging research in this rapidly developing field.

Global Health and Disease Surveillance

This track focuses on global disease monitoring and surveillance systems for protecting children from infectious diseases. Discussions will address epidemiology, health equity, and international public health collaboration. Participants will explore methods for improving early detection and response. The session will emphasize the importance of data sharing and global cooperation.

Climate Change and Emerging Infections

This session will explore how climate and environmental changes influence infectious disease patterns in children. Discussions will address the expansion of vector-borne diseases and changes in pathogen transmission. Participants will examine vulnerable populations and adaptation strategies. The session will highlight the need for climate-informed public health planning.

Novel Antimicrobial and Antiviral Therapies

This session will highlight new approaches to treating bacterial and viral infections in children. Topics will include innovative drugs, monoclonal antibodies, immunotherapies, and alternative treatment strategies. Participants will explore the challenges of developing safe pediatric therapies. The session will also examine approaches for addressing antimicrobial resistance.

Clinical Trials and Translational Research

This track focuses on clinical research and translating scientific discoveries into effective pediatric healthcare solutions. Discussions will cover drug and vaccine trials, research ethics, study design, and regulatory considerations. Participants will explore strategies for improving the inclusion of children in research. The session will highlight the importance of translating innovation into clinical practice.

Future Innovations in Pediatric Infectious Diseases

This concluding track will explore emerging technologies and future directions in pediatric infection care. Discussions will include next-generation diagnostics, advanced vaccines, novel therapeutics, and digital innovations. Participants will examine how scientific progress can improve prevention and treatment. The session will encourage new ideas and international collaboration for a healthier future for children.

Market Analysis

The 9th World Pediatric Infectious Disease Congress, scheduled for April 20–21, 2027, in Paris, France, is being organized at a time when pediatric infectious diseases continue to represent an important area of global healthcare, research, innovation, and public health investment. The increasing burden of emerging infections, antimicrobial resistance, vaccine-preventable diseases, neonatal infections, respiratory illnesses, and climate-sensitive diseases is driving continued demand for improved prevention, diagnosis, treatment, and disease surveillance. The pediatric infectious disease sector is evolving rapidly through advances in vaccine development, molecular diagnostics, genomic technologies, antimicrobial therapies, immunology, artificial intelligence, digital health, and precision medicine. These developments are creating significant opportunities for collaboration among researchers, healthcare institutions, biotechnology companies, pharmaceutical organizations, diagnostic technology providers, and public health agencies.

WHO’s Essential Programme on Immunization continues to expand protection against vaccine-preventable diseases, including several infections of major importance to child health. Antimicrobial resistance continues to create a strong need for pediatric antimicrobial stewardship, improved diagnostics, and novel therapeutic approaches. The growing resistance of bacteria, viruses, fungi, and parasites to available medicines is increasing interest in responsible antimicrobial use, surveillance systems, infection prevention, and research into innovative treatments. These challenges create important opportunities for collaboration between clinicians, researchers, pharmaceutical companies, diagnostic developers, and public health organizations.

The increasing adoption of rapid diagnostics and molecular technologies is also transforming pediatric infectious disease care. Faster pathogen identification, biomarker-based testing, genomic sequencing, and point-of-care technologies can support earlier clinical decision-making and more appropriate treatment. The integration of artificial intelligence, machine learning, digital health platforms, and telemedicine is expected to further support disease surveillance, clinical prediction, remote care, and healthcare delivery.

The biotechnology and pharmaceutical sectors continue to invest in vaccines, antimicrobial agents, antiviral therapies, monoclonal antibodies, immunotherapies, and other innovative approaches for infectious disease prevention and treatment. At the same time, advances in microbiome research, precision medicine, and genomics are opening new directions for understanding how infectious diseases affect children and how care can be better personalized. Global disease surveillance and pandemic preparedness have also become increasingly important following recent international health emergencies. Emerging pathogens, international travel, climate change, urbanization, and changing patterns of vector-borne and zoonotic diseases are increasing the need for strong surveillance and coordinated public health responses. These developments highlight the importance of global scientific collaboration and multidisciplinary approaches to protecting children from future infectious disease threats.

The pediatric infectious disease field also presents significant opportunities for academic institutions and young researchers. Increasing interest in translational research, clinical trials, vaccine development, artificial intelligence, global health, and precision medicine is encouraging new partnerships between universities, hospitals, research centers, and industry. International scientific congresses provide a valuable environment for researchers to present findings, exchange ideas, and establish collaborations. The theme of Pediatric Infectious 2027, “Global Innovations for Healthier Children: Advancing Prevention, Diagnosis and Treatment,” is therefore closely aligned with the current direction of the field. The congress will provide a strategic platform to explore scientific and technological developments while addressing global challenges in child health.

Pediatric Infectious 2027 will bring together professionals from pediatric medicine, infectious diseases, microbiology, immunology, epidemiology, public health, biotechnology, pharmaceuticals, diagnostics, and digital healthcare. The congress will create opportunities for scientific exchange, professional networking, business development, research partnerships, and exploration of future innovations.